CAS 29419-95-2
:Methyl (αS,2S)-α-phenyl-2-piperidineacetate hydrochloride (1:1)
Description:
Methyl (αS,2S)-α-phenyl-2-piperidineacetate hydrochloride is a chemical compound characterized by its specific stereochemistry and functional groups. It features a piperidine ring, which is a six-membered nitrogen-containing heterocycle, and an acetate group that contributes to its solubility and reactivity. The presence of the phenyl group enhances its lipophilicity, potentially influencing its biological activity. As a hydrochloride salt, it is typically more stable and soluble in aqueous solutions compared to its free base form. This compound is often studied in the context of medicinal chemistry due to its potential pharmacological properties, particularly in relation to its interactions with neurotransmitter systems. Its stereochemical configuration, indicated by the (αS,2S) notation, suggests specific spatial arrangements that can significantly affect its biological activity and receptor binding. Overall, this compound exemplifies the complexity of organic molecules used in pharmaceutical applications, where small changes in structure can lead to significant differences in function and efficacy.
Formula:C14H19NO2ClH
InChI:InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H/t12-,13-;/m0./s1
InChI key:InChIKey=JUMYIBMBTDDLNG-QNTKWALQSA-N
SMILES:[C@H](C(OC)=O)(C1=CC=CC=C1)[C@@]2(CCCCN2)[H].Cl
Synonyms:- 2-Piperidineacetic acid, a-phenyl-, methyl ester, hydrochloride, (aS,2S)-(-)- (8CI)
- 2-Piperidineacetic acid, a-phenyl-, methyl ester,hydrochloride, [S-(R*,R*)]-
- 2-Piperidineacetic acid, α-phenyl-, methyl ester, hydrochloride (1:1), (αS,2S)-
- 2-Piperidineacetic acid, α-phenyl-, methyl ester, hydrochloride, (αS,2S)-
- 2-Piperidineaceticacid, a-phenyl-, methyl ester,hydrochloride, (aS,2S)-(9CI)
- Methyl (αS,2S)-α-phenyl-2-piperidineacetate hydrochloride (1:1)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
L-threo-Methylphenidate Hydrochloride (1.0mg/ml in Methanol)
CAS:Controlled ProductFormula:C14H19NO2·ClHColor and Shape:Single SolutionMolecular weight:269.77L-threo-Methylphenidate Hydrochloride
CAS:Controlled Product<p>Applications Controlled substance. CNS stimulant. The less potent threo-enantiomer of Methylphenidate. The threo enantomers have shown that the pharmacological activity residues predominantly in the d-threo enantiomer.<br>References Greenblatt, E.N., et al.: J. Pharmacol. Exp. Ther., 131, 115 (1961), Padmanabhan, G.R., et al.: Anal. Profiles Drug Subs., 10, 473 (1981), Kuczenski, R., et al.: J. Pharmacol. Exp. Ther., 296, 876 (2001), Pelham, W.E., et al.: J. Consult. Clin. Psychol., 61, 506 (1993), Srinivas, N.R., et al.: Pharm. Res., 10, 14 (1993),<br></p>Formula:C14H19NO2·ClHColor and Shape:NeatMolecular weight:269.77L-Threo-methylphenidate hydrochloride
CAS:Controlled Product<p>L-Threo-methylphenidate hydrochloride is a drug used to treat ADHD. It is a central nervous system stimulant that is believed to work by increasing levels of dopamine and norepinephrine in the brain, which helps to improve symptoms of ADHD. L-Threo-methylphenidate hydrochloride can be administered orally, but has also been shown to be effective when injected into the brain or applied as a skin patch. The pharmacodynamics of L-threo methylphenidate hydrochloride are not fully understood, but it has been shown that the drug binds to both dopamine and norepinephrine transporters. Monitoring treatment with L-threo methylphenidate hydrochloride should include assessing side effects such as changes in mood, sleep patterns, weight loss or gain, heart rate, blood pressure, and blood sugar levels.</p>Formula:C14H19NO2·HClPurity:Min. 95%Molecular weight:269.77 g/mol

